HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Gatorade Laughs Last About BodyArmor Claims

Executive Summary

Coca-Cola's BA Sports argued video comparing its BodyArmor and PepsiCo business Stokely-Van Camp’s Gatorade flavors was a “social media joke” not an ad claim.

You may also be interested in...



Coca-Cola Sweats NAD Findings On Powerade Electrolyte Claims Challenged By Gatorade Maker

Coca-Cola appeals to National Advertising Review Board NAD attorneys’ recommendations that it discontinue label, social media and website claims Powerade has “50% more electrolytes* vs the leading sports drink” and “50% more electrolytes vs. Gatorade Thirst Quencher.”

NAD Says Fast-Track SWIFT Reviews Doubled Over Past Year

Greater awareness of Fast-Track SWIFT and improved understanding of cases appropriate for the process have nearly doubled the number of SWIFT cases evaluated by the National Advertising Division over the past 12 months, NAD attorney Daniel Range said at the NAD 2022 conference in Washington.

BodyArmor Not ‘Only Sports Drink’ After Gatorade Challenge, Keeps ‘Reconsider’ Choice Suggestion

NAD concludes using “Only Sports Drink” above descriptions of BodyArmor drinks in less prominent text misleadingly implies the products alone have no artificial sweeteners, flavors or dyes or have “potassium packed electrolytes.” Industry self-regulation group rejects Gatorade challenges that BodyArmor social media videos made false and misleading comparisons between the sports drink lines.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151938

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel